United Therapeutics Scores $45 Million To Develop Novel Virology Treatments
This article was originally published in The Pink Sheet Daily
Executive Summary
United Therapeutics Corp. gets a $45 million tranched grant from the U.S. National Institute of Allergy and Infectious Disease to develop broad-spectrum compounds against influenza and Dengue.